RECOVER: Phase 2 Randomized, Double-Blind Trial Treating Hospitalized Patients with COVID-19 with Camostat Mesilate, a TMPRSS2 Inhibitor

Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 (RECOVER) »